Global and temporal cortical folding in patients with early-onset schizophrenia

Journal of the American Academy of Child and Adolescent Psychiatry
Jani PenttiläA Cachia

Abstract

Adult-onset schizophrenia has repeatedly been associated with disturbances in the temporal lobes and alterations in cortical folding, which are thought to reflect neurodevelopmental impairment. Early-onset schizophrenia (EOS; onset before 18 years) is considered to involve even more pronounced neurodevelopmental deviance across a wide range of brain structural measures. We hypothesized that overall alteration of cortical folding also applies to EOS, and EOS involves prominent structural aberrations in superior temporal and collateral sulci. Magnetic resonance T1 images of 51 patients with EOS and 59 healthy participants were investigated. A fully automated method was applied to the images to extract, label, and measure the sulcus area in the whole cortex. Cortical folding was assessed by computing global sulcal indices (the ratio between total sulcal area and total outer cortex area) for each hemisphere and local sulcal indices (the ratio between the area of labeled sulcus and total outer cortex area in the corresponding hemisphere) for superior temporal and collateral sulci. Relative to healthy individuals, patients with EOS had significantly lower global sulcal indices in both hemispheres and a lower local sulcal index in the...Continue Reading

References

Jan 1, 1988·Anatomy and Embryology·K ZillesH J Kretschmann
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Aug 1, 1970·British Journal of Psychology·M Annett
Jan 1, 1995·Cerebral Cortex·E ArmstrongK Zilles
Apr 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·C Hollis
Apr 1, 1997·The American Journal of Psychiatry·H Y MeltzerP A Thompson
Jul 4, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·UNKNOWN American Academy of Child and Adolescent Psychiatry
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·P M ThompsonJ L Rapoport
Jun 20, 2003·Biological Psychiatry·Javier QuintanaJohn C Mazziotta
Aug 19, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Jon McClellanStefanie A Hlastala
Aug 29, 2003·The American Journal of Psychiatry·Paulo C SalletWagner F Gattaz
Jan 21, 2004·Biological Psychiatry·Jonathan M HarrisStephen M Lawrie
Mar 31, 2004·Biological Psychiatry·Katherine L NarrArthur W Toga
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nitin GogtayPaul M Thompson
Sep 2, 2004·Nature Neuroscience·Eileen LudersArthur W Toga
Sep 2, 2004·IEEE Transactions on Medical Imaging·J F ManginJ Régis
Oct 27, 2004·NeuroImage·J-F ManginJ Régis
Jan 26, 2005·Trends in Cognitive Sciences·Tomás Paus
May 12, 2005·Schizophrenia Research·Roger J JouMatcheri S Keshavan
Jul 5, 2005·Biological Psychiatry·Katherine L NarrRobert M Bilder
Aug 27, 2005·Schizophrenia Bulletin·Christian FleischhakerHelmut Remschmidt
Sep 15, 2005·Human Brain Mapping·Peter KochunovPeter T Fox
Dec 7, 2005·The American Journal of Psychiatry·Robyn HoneaClare E Mackay
Jan 4, 2006·Archives of General Psychiatry·Christine N VidalPaul M Thompson
Mar 25, 2006·PLoS Computational Biology·Claus C Hilgetag, Helen Barbas
Apr 21, 2006·Neurobiology of Disease·Andrea FederspielThomas Dierks
Oct 31, 2006·Psychiatry Research·Lynn E DeLisiBabak A Ardekani
Oct 31, 2006·Journal of Psychiatric Research·Peter FalkaiRalf Tepest
Nov 4, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·David G Wheeler, Clive G Harper
Apr 13, 2007·IEEE Transactions on Medical Imaging·Edouard DuchesnayJean-François Mangin
Jun 22, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Philip R SzeszkoRobert M Bilder
Aug 2, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Jean A FrazierLinmarie Sikich
Aug 3, 2007·International Review of Psychiatry·Marinos Kyriakopoulos, Sophia Frangou
Sep 5, 2007·Archives of General Psychiatry·Amélie M AchimMartin Lepage

❮ Previous
Next ❯

Citations

Aug 16, 2012·Schizophrenia Bulletin·Olivier GayArnaud Cachia
Sep 10, 2013·Child and Adolescent Psychiatric Clinics of North America·Benjamin K BrentLarry J Seidman
Sep 1, 2009·Biological Psychiatry·Joost JanssenCelso Arango
Oct 1, 2008·Journal of the American Academy of Child and Adolescent Psychiatry·Sanjiv Kumra
Feb 18, 2014·Schizophrenia Research·Tsutomu TakahashiChristos Pantelis
Dec 27, 2013·Biological Psychiatry·Pranav NandaMatcheri S Keshavan
Jun 18, 2014·NeuroImage. Clinical·G AuziasC Deruelle
Feb 17, 2010·NeuroImage·Tao LiuPerminder Sachdev
Aug 27, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Jon McClellanUNKNOWN American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI)
Jul 2, 2011·Médecine sciences : M/S·Jean-Luc Martinot, Stéphanie Mana
Sep 17, 2020·Communications Biology·Fabrizio PizzagalliNeda Jahanshad
Dec 2, 2018·Frontiers in Neuroanatomy·Antoine BouyeureMarion Noulhiane
May 22, 2010·Current Opinion in Neurology·Jean-François ManginArnaud Cachia
May 26, 2021·Pediatrics·Liwei L Hua, UNKNOWN COMMITTEE ON ADOLESCENCE

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.